Dicopanol FusePaq Kit for Oral Suspension, 5mg/ML
Published February 12, 2014 · Recall initiated: May 8, 2013
Summary
FDA records drug Class II recall D-1055-2014, published February 12, 2014 and initiated May 8, 2013. Recalling firm: Fusion Pharmaceuticals, LLC; Status: Terminated; Reported quantity: 1,200 kits; Lot: Lots: PL520, PL521, PL522 and PL523. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Microbial Contamination of Non-Sterile Products: Fusion Pharmaceuticals is recalling the Dicopanol FusePaq Kit due to Total Yeasts and Molds Count above USP limits.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Fusion Pharmaceuticals, LLC
- Distributor
- CA
- Lot
- Lots: PL520, PL521, PL522 and PL523
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACefepime for Injection USP and Dextrose Injection USP, in Duplex Drug Delivery System, 1 g in 50 mL duplexFebruary 12, 2014
- FDACornea Coat, Hydroxypropylmethylcellulose, 1.5ml Syringe, Rx Only. Manufactured by: Insight Instruments, Inc.,February 12, 2014
- FDA50 mg Nitroglycerin in 5% Dextrose Injection (200 mcg/mL), 250 mL glass containers, Baxter Healthcare Corp.,February 12, 2014
- FDAGlucotrol XL (glipizide) extended release tablets, 5 mg, 100 count bottles, Rx only, Distributed by Roerig,February 12, 2014
- FDARadial Assist RAD BOARD, used to support the weight of a patient's arm and supplies for a medical procedure.February 5, 2014
- FDAAtlantis PV, 8.5F, 15 MHz Peripheral Imaging Catheter: Sterile, R; Sterilized using irradiation. ProductFebruary 5, 2014
Questions about this recall
Was Dicopanol FusePaq Kit for Oral Suspension, 5mg/ML recalled?
Yes. FDA published recall D-1055-2014 on February 12, 2014. Reported hazard: Microbial Contamination of Non-Sterile Products: Fusion Pharmaceuticals is recalling the Dicopanol FusePaq Kit due to Total Yeasts and Molds Count above USP limits.
What should I do if I have this product?
Voluntary: Firm initiated · Letter